Acute Graft Versus Host Disease Clinical Trial
Official title:
Clinical Study of hAESCs on Prevention of Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation
This is a parallel controlled clinical study evaluating the safety and efficacy of hAECs in preventing aGVHD after HSCT.
This study is a controlled trial, with 18 subjects enrolled in the experimental group or the control group. The study will consist of four phases, including screening phase, preparation phase, hAESCs treatment phase and observational follow-up period. The cell dose of the experimental group was 1x10^6 cells/kg and the control group is infused placebo (the composition was the same as hAESCs injection excipients, but did not contain hAESCs). The infusion of hAESCs/placebo at the day before HSCT and 7th days after HSCT. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01140984 -
Intra Arterial (IA) Steroids Infusion for Hepatic Acute Hepatic Graft Versus Host Disease (aGVHD)
|
N/A | |
| Completed |
NCT00803010 -
Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation
|
Phase 2 | |
| Withdrawn |
NCT04280471 -
Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host Disease
|
Phase 1 | |
| Withdrawn |
NCT02425813 -
Methylprednisolone Sodium Succinate in Treating Patients With Acute Graft-versus-Host Disease of the Gastrointestinal Tract
|
Phase 2 | |
| Terminated |
NCT00038792 -
Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD
|
Phase 1/Phase 2 | |
| Terminated |
NCT04521777 -
Studying Changes in Physical Function Measures in Stem Cell Transplant Patients at Risk for Steroid Myopathy
|
N/A | |
| Terminated |
NCT02436460 -
A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant
|
Phase 1 | |
| Not yet recruiting |
NCT01596192 -
PETCT for Diagnosing and Monitoring Acute GVHD
|
N/A | |
| Completed |
NCT00726375 -
The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease
|
Phase 3 | |
| Recruiting |
NCT05823675 -
Safety and Clinical Activity of Itolizumab in aGVHD
|
Phase 1 | |
| Not yet recruiting |
NCT06386445 -
Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort Study
|
||
| Recruiting |
NCT05443425 -
Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies
|
Phase 1 | |
| Recruiting |
NCT03158896 -
Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease
|
Phase 1 | |
| Active, not recruiting |
NCT04976699 -
CD24Fc for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)
|
Phase 3 | |
| Terminated |
NCT04095858 -
Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)
|
Phase 3 | |
| Terminated |
NCT00032773 -
Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD
|
Phase 1/Phase 2 | |
| Completed |
NCT02359929 -
BMT Autologous MSCs for GvHD
|
Phase 1 | |
| Withdrawn |
NCT00640497 -
Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease
|
Phase 1/Phase 2 | |
| Completed |
NCT03491215 -
Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease
|
Phase 1/Phase 2 | |
| Completed |
NCT02687646 -
Clinical Trial With MSC for Graft Versus Host Disease Treatment
|
Phase 1/Phase 2 |